Results 91 to 100 of about 91,065 (316)
Novel psychoactive substances (NPS): Update, issues and challenges
Novel psychoactive substances (NPS), which emerged at the beginning of the 2000s have become a serious and internationally complex situation. These emerging drugs are mostly synthetic and analog derivatives of existing controlled drugs.
L. Ferrari
semanticscholar +1 more source
Long‐Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched Comparators
ABSTRACT Survival has improved substantially for patients with Hodgkin lymphoma (HL), but long‐term quality of life (QoL) remains incompletely understood. This was a Danish, nationwide, cross‐sectional study of QoL among persons with a diagnosis of HL matched 1:10 to general population comparators.
Sissel Johanne Godtfredsen +13 more
wiley +1 more source
Background/Objectives: The rapidly evolving crisis of Novel Synthetic Opioids (NSOs) poses a serious and growing threat for global public health. NSOs include prescription/non-prescription opioids (fentanyl, non-fentanyl analogues), herbal derivatives ...
Elena Deligianni +7 more
doaj +1 more source
Negative consequences of novel psychoactive substances use among the Polish users.
OBJECTIVES The use of the novel psychoactive substances (NPS) is a relatively new phenomenon on the Polish drug scene. At the same time, it is rapidly growing group of substances. The aim of the article is to present the negative consequences to physical,
Łukasz Wieczorek +2 more
semanticscholar +1 more source
ABSTRACT Cognitive behavioral therapy (CBT) is a well‐established, evidence‐based treatment for common mental disorders such as depression, anxiety disorders, and obsessive‐compulsive disorder (OCD). However, treatment outcomes vary widely, and a substantial proportion of patients do not achieve sufficient improvement.
Julia Bäckman +41 more
wiley +1 more source
Substance misuse services need to meet the growing demand and needs of individuals using new psychoactive substances (NPS). A review of the literature identified a paucity of research regarding NPS use by these individuals and UK guidelines outline the ...
Rosalind Gittins +3 more
doaj +1 more source
Autism Spectrum Disorder Among Gender‐Diverse Children and Adolescents: A National Cohort Study
ABSTRACT Autism spectrum disorder (ASD) is more prevalent in transgender and gender‐diverse (TGD) individuals than in the general population, yet the specific developmental pathways within and clinical outcomes of this intersection are insufficiently understood.
Erez Topaz +7 more
wiley +1 more source
An index of fatal toxicity for new psychoactive substances [PDF]
The final, definitive version of this paper has been published in Journal of Psychopharmacology, February 2018, published by SAGE Publishing, All rights reserved.An index of fatal toxicity for new psychoactive substances has been developed based solely ...
Corkery, John, King, L.A.
core +2 more sources
ABSTRACT The aim of this study was to examine time perception (i.e., the sense of the duration, order and passage of time) and event‐ and time‐based prospective memory (PM; i.e., the ability to recall an intention to perform an action in the future) in adults across the wider autism spectrum including those with intellectual disabilities.
Daniela Nürnberg, Mareike Altgassen
wiley +1 more source
Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and “Smart Drug” Use and Misuse
Whilst “nootropics” are meant to treat a range of medical disorder-related cognitive impairments, the typically healthy “smart drugs” user ingests a range of drugs/molecules to achieve improved mental performance.
Fabrizio Schifano +6 more
doaj +1 more source

